References

  1. Data on file, Janssen Pharmaceuticals, Inc.

    2.  

  2. Owens RC Jr, Shorr AF. Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies. Am J Health Syst Pharm. 2009;66(12 suppl 4):S23-S30.

    3.  

  3. Turnidge JD. The pharmacodynamics of beta-lactams. Clin Infect Dis. 1998;27:10-22.

    4.  

  4. Nicolau DP. Pharmacokinetic and pharmacodynamic properties of meropenem. Clin Infect Dis. 2008;47(suppl 1):S32-S40.

    5.  

  5. Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clin Ther. 2008;30:868-883.